A photo of Patrick Whitlock.

Co-Director Hip Preservation Center

Orthopaedic Surgeon, Division of Pediatric Orthopaedics

Assistant Professor, UC Department of Orthopedic Surgery


Board Certified

About Me


As a hip surgeon and co-director of the Hip Preservation Program at Cincinnati Children’s, I treat children, adolescents and young adults with orthopaedic trauma, hip dysplasia, Perthes disease, slipped capital femoral epiphysis (SCFE) and femoroacetabular impingement (FAI). I also perform hip arthroscopy. I strive to always provide evidence-based care that is personalized, detailed and the result of shared decision-making with our team and the patient or family.

My career is driven by the opportunity to have a positive impact on patients’ lives. I’m focused on the hip because it plays an important role in the development and the lives of our patients. By addressing diseases and conditions of the hip in young patients, we have the greatest possible impact on them throughout their lives, in our own and extended communities.

Within the Hip Preservation Program at Cincinnati Children’s, our team spends many hours reviewing imaging studies, therapy reports, notes from other physicians and our own exams. When a patient sees one team member, they benefit from the opinion of our entire hip-preservation team.

In addition to helping patients, I’m also involved in research. As a surgeon scientist, I have worked with our team to develop a multidisciplinary effort to advance the development, characterization and translation of naturally derived biomaterials to treat orthopaedic injuries and pathologies in children, adolescents and young adults. These conditions include avascular necrosis, large osteochondral defects and growth plate injuries, all of which represent a critical need for a clinically effective solution where none currently exists. Our Angela S. M. Kuo Award from the Pediatric Orthopaedic Society of North America (POSNA) recently funded our research into bioinductive scaffolds created by additive manufacturing for the treatment of large osteochondral defects.

My research has been presented at numerous national and international professional meetings, and I have authored multiple book chapters and publications related to both my clinical and translation research. Other awards include several patents related to the development of naturally derived biomaterials.

I was honored to receive the 2013 Maurice E. Muller Traveling Fellowship in Hip Reconstruction. I also received the 2017 POSNA-SLAOTI Pediatric Orthopaedic Surgery Traveling Fellowship, which took me to Chile, Argentina and Brazil to learn new techniques and exchange ideas. I was named an Emerging Leader by the American Orthopaedic Association (AOA).

In my spare time, I enjoy being outdoors with my son and my wife, who is also a local physician. As a family, we enjoy music, movies, travel, mountain biking, fishing, climbing, rowing and surfing.

Clinical Interests

Hip preservation; SCFE; developmental dysplasia of the hip; Legg-Calves-Perthes disease; femoro-acetabular impingement

Research Interests

Regenerative medicine; biomaterials; musculoskeletal development; naturally-derived tissue scaffolds; clinical outcomes research

Academic Affiliation

Assistant Professor, UC Department of Orthopedic Surgery


Orthopaedic Surgery, Hip Preservation

Cincinnati Children's Blog

Hip Dysplasia as an Adult

BlogRare and Complex Conditions

Hip Dysplasia as an Adult: Tips Following Surgical Treatment

By Shannon Robertshaw Carroll11/2/2017

My Locations

My Education

PhD: University of Cincinnati College of Engineering, Cincinnati, OH, 2005.

MD: Drexel University College of Medicine, Philadelphia, PA, 2005,

Residency: Wake Forest Health Sciences, Winston-Salem, NC, 2012.

Fellowships: Maurice E. Muller Foundation of North America European Traveling Fellowship in Hip Reconstruction, Switzerland, Denmark, Italy, 2013; Pediatric Orthopaedic Surgery, Children's Hospital Los Angeles, Los Angeles, CA, 2014.

My Publications

Investigating the Osteoinductive Potential of a Decellularized Xenograft Bone Substitute. Bracey, DN; Jinnah, AH; Willey, JS; Seyler, TM; Hutchinson, ID; Whitlock, PW; Smith, TL; Danelson, KA; Emory, CL; Kerr, BA. Cells, Tissues, Organs: in vivo, in vitro. 2019; 207:97-113.

A Dedicated Fracture Reduction Room: A Cost-Effective Alternative to the Operating Room. Whitlock, PW; Little, KJ; Singleton, SS; Mahmoud, M; Ngamprasertwong, P; McCarthy, JJ. Journal of the American Academy of Orthopaedic Surgeons. 2019; 27:e887-e892.

A porcine xenograft-derived bone scaffold is a biocompatible bone graft substitute: An assessment of cytocompatibility and the alpha-Gal epitope. Bracey, DN; Seyler, TM; Jinnah, AH; Smith, TL; Ornelles, DA; Deora, R; Parks, GD; Van Dyke, ME; Whitlock, PW. Xenotransplantation. 2019; 26.

Reliability and normative values of common adult radiographic parameters for hip preservation in the developing pelvis. Whitlock, PW; Salari, KF; Blumstein, G; Zhang, B; Arkader, A; Choi, P. Journal of Hip Preservation Surgery. 2019; 6:189-198.

Novel Process for 3D Printing Decellularized Matrices. Gruber, SM S; Ghosh, P; Mueller, KW; Whitlock, PW; Lin, C. Jove-Journal of Visualized Experiments. 2019; 2019.

Use of a Clinical Care Algorithm to Improve Care for Children With Hematogenous Osteomyelitis. Robinette, ED; Brower, L; Schaffzin, JK; Whitlock, P; Shah, SS; Connelly, B; Team, AH O C A. Pediatrics. 2019; 143:e20180387-e20180387.

Pulseless Supracondylar Humerus Fracture With Anterior Interosseous Nerve or Median Nerve Injury-An Absolute Indication for Open Reduction?. Harris, LR; Arkader, A; Broom, A; Flynn, J; Yellin, J; Whitlock, P; Miller, A; Sawyer, J; Roaten, J; Skaggs, DL; et al. Journal of Pediatric Orthopaedics. 2019; 39:e1-e7.

A decellularized porcine xenograft-derived bone scaffold for clinical use as a bone graft substitute: A critical evaluation of processing and structure. Bracey, DN; Seyler, TM; Jinnah, AH; Lively, MO; Willey, JS; Smith, TL; van Dyke, ME; Whitlock, PW. Journal of Functional Biomaterials. 2018; 9:45-45.

Microspheres containing decellularized cartilage induce chondrogenesis in vitro and remain functional after incorporation within a poly(caprolactone) filament useful for fabricating a 3D scaffold. Ghosh, P; Gruber, SM S; Lin, C; Whitlock, PW. Biofabrication. 2018; 10:025007-025007.

The Development of a Xenograft-Derived Scaffold for Tendon and Ligament Reconstruction Using a Decellularization and Oxidation Protocol. Seyler, TM; Bracey, DN; Plate, JF; Lively, MO; Mannava, S; Smith, TL; Saul, JM; Poehling, GG; Van Dyke, ME; Whitlock, PW. Arthroscopy: The Journal of Arthroscopy and Related Surgery. 2017; 33:374-386.